Australia markets open in 2 minutes

Surgery Partners, Inc. (SGRY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
30.18-0.81 (-2.61%)
At close: 04:00PM EDT
30.18 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.84B
Enterprise value 7.05B
Trailing P/E 2.69k
Forward P/E 22.68
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.32
Price/book (mrq)1.97
Enterprise value/revenue 2.44
Enterprise value/EBITDA 14.90

Trading information

Stock price history

Beta (5Y monthly) 2.76
52-week change 3-7.88%
S&P500 52-week change 320.52%
52-week high 336.92
52-week low 322.05
50-day moving average 328.64
200-day moving average 329.14

Share statistics

Avg vol (3-month) 31.15M
Avg vol (10-day) 31.28M
Shares outstanding 5127.12M
Implied shares outstanding 6127.12M
Float 874.85M
% held by insiders 11.12%
% held by institutions 1113.24%
Shares short (15 Aug 2024) 411.32M
Short ratio (15 Aug 2024) 49.31
Short % of float (15 Aug 2024) 419.59%
Short % of shares outstanding (15 Aug 2024) 48.90%
Shares short (prior month 15 July 2024) 412.27M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin -1.17%
Operating margin (ttm)14.51%

Management effectiveness

Return on assets (ttm)3.96%
Return on equity (ttm)3.73%

Income statement

Revenue (ttm)2.89B
Revenue per share (ttm)22.94
Quarterly revenue growth (yoy)14.20%
Gross profit (ttm)N/A
EBITDA 575.6M
Net income avi to common (ttm)-33.8M
Diluted EPS (ttm)-0.26
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)253.7M
Total cash per share (mrq)2.01
Total debt (mrq)3.44B
Total debt/equity (mrq)95.16%
Current ratio (mrq)1.84
Book value per share (mrq)15.45

Cash flow statement

Operating cash flow (ttm)290.7M
Levered free cash flow (ttm)163.25M